Your IPSS Score, Explained
Seven questions, a number from 0 to 35, and an eighth question that matters more than the total. It measures how much your symptoms bother you — not the size of your prostate.
Find out in under a minute – no phone call needed.
On this page
You filled in a questionnaire in the waiting room, someone added it up, and you left with a number. The IPSS is the standard way urologists measure how much an enlarged prostate is affecting you — and unlike most numbers in medicine, it is entirely made of your own answers. It measures bother, not anatomy.
What the IPSS Is
The International Prostate Symptom Score is an eight-question form. Seven questions ask how often you experience particular urinary symptoms, each scored from 0 to 5, giving a total between 0 and 35. The eighth is scored separately and asks how you feel about it.
It is used everywhere, for two reasons. It sorts men into severity bands that guide treatment, and it gives a repeatable number, so the same questionnaire before and after treatment shows whether anything actually improved. Almost every study quoted in BPH treatment is reporting IPSS change.
The Seven Questions
Each asks how often, over the past month, you have experienced:
- Incomplete emptying — the sense that your bladder is not empty afterwards
- Frequency — needing to go again within two hours
- Intermittency — the stream stopping and starting
- Urgency — difficulty postponing
- Weak stream
- Straining — having to push to begin
- Nocturia — how many times you get up at night
The first six are scored 0 (not at all) to 5 (almost always). Nocturia is scored by number of times, 0 to 5 or more. Note what is absent: nothing about pain, nothing about blood, nothing about sexual function. Those matter clinically, and the IPSS was not built to capture them.
What Your Score Means
Mild symptoms
Within the range of many men who consider themselves untroubled. Community studies of men aged 50 to 80 without significant urinary complaints found mean scores rising only from about 4 to 7 across those decades.
Usually: Watchful waiting and lifestyle adjustment. Treatment is not generally recommended on a score alone at this level.
Moderate symptoms
Where most men sit when they finally raise it with a doctor. Symptoms are affecting daily life but have not become disabling.
Usually: Medication is typically offered first. Procedural treatment is a reasonable discussion, particularly if medication has not worked or its side effects are unwelcome.
Severe symptoms
Substantially disruptive — broken sleep, planning around bathrooms, real limits on daily life.
Usually: Active treatment discussion. Medication alone often underdelivers at this level, and procedural options move to the foreground.
For context on what treatment can shift: in a series of men with very large prostates and severe symptoms, mean IPSS fell from 26.5 to 10.5 over two years after PAE — from the top of the severe band into mild. In trials against combined medication, PAE produced roughly a 10-point greater IPSS improvement.
The Eighth Question
The final question is scored separately, 0 to 6, and asks how you would feel about spending the rest of your life with your urinary symptoms exactly as they are now.
It is the most useful question on the form and the one most often skipped past. Two men with identical scores of 14 can answer it completely differently, and the man who answers “mostly dissatisfied” needs a different conversation from the man who answers “mostly satisfied.” Community data show that quality-of-life scores stay flat with age even as symptom scores climb — meaning many men adapt. Whether you have adapted, or resigned yourself, is what this question is really asking.
What Happens at Each Level
The score does not decide your treatment on its own. It combines with your prostate volume, your flow rate, how much urine remains after voiding, your PSA, and whether you have had complications like retention or infection.
What the score does control is whether treatment is on the table at all. Most guidelines and most insurers expect at least moderate symptoms — a score above 7, sometimes above 12 — before approving a procedure. If you are seeking treatment, this number is frequently the gatekeeper, which is a practical reason to fill the form in honestly rather than stoically.
Fill it in for a normal month
Men routinely understate. If you have quietly stopped drinking after 7pm, mapped the bathrooms on your commute, or moved to the spare room so you do not wake your partner getting up, those adaptations are the symptom — answer for what would happen without them. A score that reflects your workarounds rather than your bladder will steer your care wrongly.
What the Score Misses
- It does not measure obstruction. A weak bladder muscle produces similar answers to a blocked outlet, and the treatments differ completely. Flow rate and post-void residual separate them.
- It does not reflect prostate size. The correlation between gland volume and IPSS is consistently weak — men with 80 mL prostates sometimes score mild, and men with 30 mL prostates sometimes score severe.
- It is not specific to the prostate. Overactive bladder, diabetes, diuretics, sleep apnea, and simple fluid habits all raise the score.
- Nocturia distorts it. Getting up at night is often the biggest single contributor, and it has causes that have nothing to do with the prostate.
- It captures a month. Recent illness, a bad week, or a new medication can shift it.
Where Prostate Artery Embolization Fits
PAE treats an enlarged prostate from the inside of the blood vessels rather than through the urethra. A catheter is threaded from a pinhole in the wrist or groin to the small arteries feeding the prostate, and microscopic particles are released to reduce its blood supply. The gland shrinks over the following months and the pressure on the urethra eases. There is no incision, no general anesthetic, no instrument passed through the penis, and no overnight stay.
Because it works through the arteries instead of the prostatic urethra, PAE avoids the bladder neck entirely. That anatomical difference is why it behaves so differently from the transurethral procedures on the one measure men care about most and are least often asked about.
That last figure belongs here rather than buried. PAE trades durability for safety and functional preservation. Around one man in five needs something further within five years, against a much lower rate after resective surgery. In the largest long-term series, 88% of men had still avoided prostatectomy at five years, and a repeat PAE kept most of those who needed more treatment out of surgery altogether. Whether that trade is worth it depends on what you are optimising for, and it is a legitimate reason some men choose TURP or HoLEP instead.
PAE entered the American Urological Association guideline in the 2023 amendment, and the European Association of Urology guideline the same year. The previous AUA guideline had recommended against it outside clinical trials, so this is a genuine change in standing rather than marketing language — and it is the reason insurance coverage has improved. Our insurance page covers how we handle authorisation, and the office can check your benefits directly.
California Prostate Center
Atabak Allaei, MD
- Double board-certified in Vascular & Interventional Radiology and Diagnostic Radiology
- Attending staff at Cedars-Sinai Medical Center and UCI Health
- More than 10,000 image-guided procedures performed
- Focused practice in prostate artery embolization, including large glands and men who are poor candidates for surgery
Appointments in Beverly Hills, Pomona, and Orange County, or by video telehealth. Bring your prostate volume measurement, recent PSA, and IPSS score if you have them.
Common Questions
What is a bad IPSS score?
0 to 7 is mild, 8 to 19 moderate, and 20 to 35 severe. Most men seeking help score in the moderate range. The separate quality-of-life question matters as much as the total, because how much the symptoms bother you drives treatment as strongly as the number does.
Does a high IPSS mean I need surgery?
Not on its own. A high score means symptoms are significant, but the treatment depends on prostate size, flow rate, residual urine, and whether obstruction is the actual cause. Medication is often tried first. A high score does generally mean the conversation should move beyond watchful waiting.
Does my score reflect how big my prostate is?
Only loosely. Published studies find a weak correlation between prostate volume and IPSS. Where the tissue sits matters more than how much of it there is, which is why size and symptoms are assessed separately.
How much can treatment improve my score?
It varies with the treatment and your starting point. After PAE, men with severe symptoms from very large prostates saw mean scores fall from 26.5 to 10.5 over two years, and PAE outperformed combined medication by roughly 10 points in comparative work. TURP and HoLEP produce comparable or slightly greater improvement with different trade-offs.
Should I retake the IPSS?
Yes, that is what it is designed for. Repeating it every six to twelve months, and before and after any treatment, turns a single number into a trend. Bring previous scores to appointments — the change is more informative than any one reading.
References
- Berges R, Oelke M. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators. World J Urol. 2011;29(2):171–178. Mean IPSS rose from 4 to 7 across ages 50 to 80 while QoL remained unchanged at 2; prostate size had a minor impact on IPSS.
- Correlation between prostate volume measured by ultrasound and symptom severity score in patients with BPH. Weak positive correlation between prostate volume and IPSS.
- Prostate artery embolization has long-term efficacy for severe LUTS from giant prostatic hyperplasia. Mean IPSS 26.5 to 18.0 to 10.5 at baseline, 12 and 24 months.
- Prostate artery embolism is a new alternative for BPH. AUA Daily News, 2024. PAE showed a 10-point IPSS improvement over combined medical therapy.
This article is for general education and does not replace an evaluation by a qualified physician. Individual results vary. See our disclaimer.
Find out whether PAE fits your prostate
Dr. Allaei reviews your imaging, PSA and symptom scores himself and tells you plainly whether embolization suits your anatomy, what to expect, and when another treatment is the better answer.
